Your browser doesn't support javascript.
loading
Risk of Hospital-Acquired Acute Kidney Injury among Adult Opioid Analgesic Users: A Multicenter Real-World Data Analysis.
Pi, Mingjing; Nie, Sheng; Su, Licong; Li, Yanqin; Cao, Yue; Gao, Peiyan; Lin, Yuxin; Zha, Yan; Shi, Yongjun; Li, Hua; Zhao, Jiajun; Kong, Yaozhong; Li, Guisen; Hu, Ying; Liu, Huafeng; Wan, Qijun; Chen, Chunbo; Liu, Bicheng; Yang, Qiongqiong; Su, Guobin; Zhou, Yilun; Weng, Jianping; Xu, Gang; Xu, Hong; Tang, Ying; Gong, Mengchun; Hou, Fan Fan; Xu, Xin.
Affiliation
  • Pi M; Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China.
  • Nie S; Department of Nephrology, Guizhou Provincial People's Hospital, Guizhou University, Guiyang, China.
  • Su L; Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China.
  • Li Y; Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China.
  • Cao Y; Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China.
  • Gao P; Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China.
  • Lin Y; Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China.
  • Zha Y; Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China.
  • Shi Y; Department of Nephrology, Guizhou Provincial People's Hospital, Guizhou University, Guiyang, China.
  • Li H; Department of Nephrology, Huizhou Municipal Central Hospital, Sun Yat-Sen University, Huizhou, China.
  • Zhao J; Department of Nephrology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Kong Y; Department of Endocrinology, Shandong Provincial Hospital, Jinan, China.
  • Li G; Department of Nephrology, The First People's Hospital of Foshan, Foshan, China.
  • Hu Y; Renal Department and Institute of Nephrology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Sichuan Clinical Research Center for Kidney Diseases, Chengdu, China.
  • Liu H; Department of Nephrology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Wan Q; Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
  • Chen C; The Second People's Hospital of Shenzhen, Shenzhen University, Shenzhen, China.
  • Liu B; Department of Critical Care Medicine, Maoming People's Hospital, Maoming, China.
  • Yang Q; Institute of Nephrology, Zhongda Hospital, Southeast University School of Medicine, Nanjing, China.
  • Su G; Department of Nephrology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Zhou Y; Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital, The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Weng J; Department of Nephrology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Xu G; Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Xu H; Division of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Tang Y; Children's Hospital of Fudan University, Shanghai, China.
  • Gong M; The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Hou FF; Institute of Health Management, Southern Medical University, Guangzhou, China.
  • Xu X; Digital China Health Technologies, Beijing, China.
Kidney Dis (Basel) ; 9(6): 517-528, 2023 Dec.
Article in En | MEDLINE | ID: mdl-38089444
ABSTRACT

Introduction:

Comprehensive data on the risk of hospital-acquired (HA) acute kidney injury (AKI) among adult users of opioid analgesics are lacking. This study aimed to systematically compare the risk of HA-AKI among the users of various opioid analgesics.

Methods:

This multicenter, retrospective real-world study analyzed 255,265 adult hospitalized patients who received at least one prescription of opioid analgesic during the first 30 days of hospitalization. The primary outcome was the time from the first opioid analgesic prescription to HA-AKI occurrence. 12 subtypes of opioid analgesics were analyzed, including 9 for treating moderate-to-severe pain and 3 for mild-to-moderate pain. We examined the association between the exposure to each subtype of opioid analgesic and the risk of HA-AKI using Cox proportional hazards models, using the most commonly used opioid analgesic as the reference group.

Results:

As compared to dezocine, the most commonly used opioid analgesic for treating moderate-to-severe pain, exposure to morphine, but not the other 7 types of opioid analgesics, was associated with a significantly increased risk of HA-AKI (adjusted hazard ratio 1.56, 95% confidence interval 1.40-1.78). The association was consistent in stratified analyses and in a propensity-matched cohort. There were no significant differences in the risk of HA-AKI among the opioid analgesic users with mild-to-moderate pain after adjusting for confounders.

Conclusion:

The use of morphine was associated with an increased risk of HA-AKI in adult patients with moderate-to-severe pain. Opioid analgesics other than morphine should be chosen preferentially in adult patients with high risk of HA-AKI when treating moderate-to-severe pain.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Kidney Dis (Basel) Year: 2023 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Kidney Dis (Basel) Year: 2023 Type: Article Affiliation country: China